Cost-Effectiveness of Nivolumab Plus Chemotherapy vs. Chemotherapy as First-Line Treatment for Advanced Gastric Cancer/Gastroesophageal Junction Cancer/Esophagel Adenocarcinoma in China

ObjectiveThe purpose of this study was to evaluate the cost-effectiveness of nivolumab plus chemotherapy vs. chemotherapy as first-line therapy in patients with advanced gastric cancer/gastroesophageal junction cancer/esophageal adenocarcinoma from the perspective of the Chinese healthcare system.Me...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Yamin Shu, Yufeng Ding, Qilin Zhang
Format: Artigo
Sprog:Inglês
Udgivet: Frontiers Media S.A. 2022-04-01
Serier:Frontiers in Oncology
Fag:
cost-effectiveness analysis
gastric cancer/gastroesophageal junction cancer/esophageal adenocarcinoma
nivolumab
CheckMate 649 trial
first-line treatment
Online adgang:https://www.frontiersin.org/articles/10.3389/fonc.2022.851522/full
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker